Current and historical daily PE Ratio for Aspen Pharmacare Holdings Ltd (
) from 2006 to Apr 30 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Aspen Pharmacare stock (APNHF) PE ratio as of Apr 30 2024 is 20.14.
More Details
Aspen Pharmacare Holdings Ltd (APNHF) PE Ratio (TTM) Chart
Aspen Pharmacare Holdings Ltd (APNHF) PE Ratio (TTM) Historical Data
View and export this data going back to 2006. Start your Free Trial
Total 1216
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Aspen Pharmacare PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-01 | 15.7 | 2024-02-26 | 15.7 |
| 2024-04-29 | 15.7 | 2024-02-23 | 15.7 |
| 2024-04-26 | 15.7 | 2024-02-22 | 15.7 |
| 2024-04-25 | 15.7 | 2024-02-21 | 15.7 |
| 2024-04-24 | 15.7 | 2024-02-20 | 15.7 |
| 2024-04-23 | 15.7 | 2024-02-16 | 15.7 |
| 2024-04-22 | 15.7 | 2024-02-15 | 15.7 |
| 2024-04-19 | 15.7 | 2024-02-14 | 15.7 |
| 2024-04-18 | 15.7 | 2024-02-13 | 15.7 |
| 2024-04-17 | 15.7 | 2024-02-12 | 15.7 |
| 2024-04-16 | 15.7 | 2024-02-09 | 15.7 |
| 2024-04-15 | 15.7 | 2024-02-08 | 15.7 |
| 2024-04-12 | 15.7 | 2024-02-07 | 15.7 |
| 2024-04-11 | 15.7 | 2024-02-06 | 15.7 |
| 2024-04-10 | 15.7 | 2024-02-05 | 15.7 |
| 2024-04-09 | 15.7 | 2024-02-02 | 15.7 |
| 2024-04-08 | 15.7 | 2024-02-01 | 15.7 |
| 2024-04-05 | 15.7 | 2024-01-31 | 15.7 |
| 2024-04-04 | 15.7 | 2024-01-30 | 15.7 |
| 2024-04-03 | 15.7 | 2024-01-29 | 15.7 |
| 2024-04-02 | 15.7 | 2024-01-26 | 15.7 |
| 2024-04-01 | 15.7 | 2024-01-25 | 15.7 |
| 2024-03-28 | 15.7 | 2024-01-24 | 15.7 |
| 2024-03-27 | 15.7 | 2024-01-23 | 15.7 |
| 2024-03-26 | 15.7 | 2024-01-22 | 15.7 |
| 2024-03-25 | 15.7 | 2024-01-19 | 15.7 |
| 2024-03-22 | 15.7 | 2024-01-18 | 15.7 |
| 2024-03-21 | 15.7 | 2024-01-17 | 15.7 |
| 2024-03-20 | 15.7 | 2024-01-16 | 15.7 |
| 2024-03-19 | 15.7 | 2024-01-12 | 15.7 |
| 2024-03-18 | 15.7 | 2024-01-11 | 15.7 |
| 2024-03-15 | 15.7 | 2024-01-10 | 15.7 |
| 2024-03-14 | 15.7 | 2024-01-09 | 15.7 |
| 2024-03-13 | 15.7 | 2024-01-08 | 15.7 |
| 2024-03-12 | 15.7 | 2024-01-05 | 15.7 |
| 2024-03-11 | 15.7 | 2024-01-04 | 15.7 |
| 2024-03-08 | 15.7 | 2024-01-03 | 15.7 |
| 2024-03-07 | 15.7 | 2024-01-02 | 15.7 |
| 2024-03-06 | 15.7 | 2023-12-29 | 15.7 |
| 2024-03-05 | 15.7 | 2023-12-28 | 15.7 |
| 2024-03-04 | 15.7 | 2023-12-27 | 14.1 |
| 2024-03-01 | 15.7 | 2023-12-26 | 14.1 |
| 2024-02-29 | 15.7 | 2023-12-22 | 14.1 |
| 2024-02-28 | 15.7 | 2023-12-21 | 14.1 |
| 2024-02-27 | 15.7 | 2023-12-20 | 14.1 |
Aspen Pharmacare Holdings Ltd (APNHF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Aspen Pharmacare Holdings Ltd
ISIN : ZAE000066692
Compare
Compare
Traded in other countries / regions
APN.South AfricaAPNHY.USALDZA.Germany IPO Date
2006-01-25Description
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers